Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19
Cardiovascular Medicine
[키워드] ACE2
alteration
angiotensin-converting enzyme 2
Arterial hypertension
Artery
binding
blood flow
cardiovascular
catalytic domain
cause
cell entry
clinical study
Context
contribute
COVID-19
death
Deleterious
diagnosed with COVID-19
disease
Endothelial dysfunction
event
events
Evidence
feature
Hyperactivation
Inflammation
Inflammatory
knowledge
Local
morbidity and mortality
New
Occurrence
organs
oxidative
oxidative and inflammatory stress
oxidative stress
PAH
paradigm
pathology
pathophysiology
pathway
Patient
prevalent
primary arterial hypertension
Protein
RAS
regulate
renin–angiotensin–aldosterone system
reported
resistance
responsible
risk
SARS-CoV2
small resistance arteries
small vessel
Stress
thrombosis
tissue
Vascular
virus
[DOI] 10.3389/fcvm.2020.588692 PMC 바로가기 [Article Type] Cardiovascular Medicine
[DOI] 10.3389/fcvm.2020.588692 PMC 바로가기 [Article Type] Cardiovascular Medicine